Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery (Q24202939)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6465036&resulttype=core&format=json

14 May 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6465036&resulttype=core&format=json

14 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6465036&resulttype=core&format=json

14 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6465036&resulttype=core&format=json

14 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6465036&resulttype=core&format=json

14 May 2020

Gillian E Mead

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6465036&resulttype=core&format=json

14 May 2020

Rebecca Lee

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6465036&resulttype=core&format=json

14 May 2020

Anne Claxton

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6465036&resulttype=core&format=json

Cochrane Database of Systematic Reviews

14 May 2020

publication date

14 November 2012

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6465036&resulttype=core&format=json

14 May 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6465036&resulttype=core&format=json

14 May 2020

page(s)

CD009286

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6465036&resulttype=core&format=json

A double blind placebo RCT to investigate the effects of serotonergic modulation on brain excitability and motor recovery in stroke patients

14 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Fluoxetine as a treatment for post-stroke emotionalism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Sertraline in stroke-associated lability of mood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Influence of Jieyu Huoxue Decoction on rehabilitation of patients with depression after cerebral infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

[Interpersonal psychotherapy and pharmacotherapy for post-stroke depression. Feasibility and effectiveness].

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) and fluoxetine on post-stroke depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Mortality and poststroke depression: a placebo-controlled trial of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Preventing poststroke depression: a 12-week double-blind randomized treatment trial and 21-month follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Escitalopram and enhancement of cognitive recovery following stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Incomplete financial disclosure in a study of escitalopram and problem-solving therapy for prevention of poststroke depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Fluoxetine improves the quality of life in patients with poststroke emotional disturbances

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Depressive disorders in neurologic rehabilitation: therapy with paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Clinical Studies on Event-Related Potentials (ERPS) N400 and the Related Factors in Patients with Poststroke Depression (PSD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Therapeutic effects of milnacipran, a serotonin and noradrenaline reuptake inhibitor, on post-stroke depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

A single dose of the serotonin neurotransmission agonist paroxetine enhances motor output: double-blind, placebo-controlled, fMRI study in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Prediction of the response to citalopram and reboxetine in post-stroke depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Fluoxetine vs placebo for depressive symptoms after stroke: failed randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Efficacy of milnacipran on cognitive dysfunction with post-stroke depression: preliminary open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Cognitive improvement after treatment of depressive symptoms in the acute phase of stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Sertraline in the treatment of post-stroke depression--results of an open multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Citalopram improves dexterity in chronic stroke patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Heterocyclics and selective serotonin reuptake inhibitors in the treatment and prevention of poststroke depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Antidepressants in the treatment of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Treatment effects of antidepressants in patients with post-stroke depression: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Antidepressant prophylaxis for poststroke depression: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Interventions for treating depression after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Interventions for preventing depression after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Pharmaceutical interventions for emotionalism after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Rate, degree, and predictors of recovery from disability following ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Time frame and predictors of recovery from disability following recurrent ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

State of the art of the neurotrophin hypothesis in psychiatric disorders: implications and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Fluoxetine affords robust neuroprotection in the postischemic brain via its anti-inflammatory effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Cerebral functional magnetic resonance imaging activation modulated by a single dose of the monoamine neurotransmission enhancers fluoxetine and fenozolone during hand sensorimotor tasks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Adult neurogenesis in the mammalian central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Selective serotonin-reuptake inhibitors and recovery after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Fluoxetine and sertraline attenuate postischemic brain injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Meta-analysis of individual patient data from randomized trials: a review of methods used in practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Preventing stroke: saving lives around the world

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Pharmacologic treatment of poststroke depression: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Repairing brain after stroke: a review on post-ischemic neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Fluoxetine for the prophylaxis of poststroke depression in patients with stroke: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Preventing Depression After Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

Sertraline in stroke-associated lability of mood

21 January 2018

1 reference

12 December 2020

Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study

1 reference

12 December 2020

Experience from a multicentre stroke register: a preliminary report

1 reference

12 December 2020

Fluoxetine in early poststroke depression: a double-blind placebo-controlled study

1 reference

12 December 2020

Post-stroke depression: an experience in using cipramil

1 reference

12 December 2020

Post-ischemia neurologic recovery

1 reference

12 December 2020

Sertraline treatment of post-stroke major depression: an open study in patients with moderate to severe symptoms.

1 reference

12 December 2020

Coaxil efficacy in depression in patients with chronic cerebral ischemia

1 reference

12 December 2020

Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression

1 reference

12 December 2020

The brain-resuscitation acupuncture method for treatment of post wind-stroke mental depression--a report of 45 cases.

1 reference

12 December 2020

Adult neurogenesis and neuroplasticity

1 reference

12 December 2020

Preventing depression after stroke: Results from a randomized placebo-controlled trial.

1 reference

12 December 2020

[Clinical effectiveness and safety of paroxetine in post-stroke depression: results from a phase 4, open label, multicenter clinical trial with 26 weeks of follow-up]

1 reference

12 December 2020

[Observation on effect of Wuling Capsule in treating poststroke depression]

1 reference

12 December 2020

Single dose of fluoxetine increases muscle activation in chronic stroke patients.

1 reference

12 December 2020

Effects of Linggui Bafa on the therapeutic effect and quality of life in patients of post-stroke depression

1 reference

12 December 2020

The clinical use of drugs influencing neurotransmitters in the brain to promote motor recovery after stroke; a Cochrane systematic review

1 reference

12 December 2020

Clinical observation on acupuncture treatment of 150 cases of post-stroke depression according to syndrome differentiation

1 reference

12 December 2020

Effective treatment of depression following apoplexy with citalopram

1 reference

12 December 2020

Up-regulation of beta 1-adrenergic receptors in rat brain after chronic citalopram and fluoxetine treatments

1 reference

12 December 2020

Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram

1 reference

12 December 2020

[Therapy of post-stroke depression with fluoxetine. A pilot project]

1 reference

12 December 2020

Effects of early treatment of poststroke depression on neuropsychological rehabilitation

1 reference

12 December 2020

Correlation of the Cerebral Microvascular Blood Flow with Brain Temperature and Electro-Acupuncture Stimulation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

7 January 2021

inferred from DOI database lookup

Long-term administration of fluoxetine to improve motor recovery after stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009286.PUB2

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/14651858.CD009286.PUB2

2 references

Consolidated OpenCitations Corpus – April 2017

3544337

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6465036&resulttype=core&format=json

14 May 2020

3544337

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6465036&resulttype=core&format=json

14 May 2020

PubMed publication ID

23152272

2 references

Consolidated OpenCitations Corpus – April 2017

3544337

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6465036&resulttype=core&format=json